| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 1.77e-09 | 4 | 131 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 1.77e-09 | 4 | 131 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 1.77e-09 | 4 | 131 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 8.80e-09 | 5 | 131 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 8.80e-09 | 5 | 131 | 4 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 8.80e-09 | 5 | 131 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 8.80e-09 | 5 | 131 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 8.80e-09 | 5 | 131 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 8.80e-09 | 5 | 131 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 8.80e-09 | 5 | 131 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 2.63e-08 | 6 | 131 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 6.10e-08 | 7 | 131 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 1.21e-07 | 8 | 131 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 1.21e-07 | 8 | 131 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 1.21e-07 | 8 | 131 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 2.17e-07 | 9 | 131 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 2.17e-07 | 9 | 131 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 3.60e-07 | 10 | 131 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 3.60e-07 | 10 | 131 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 4.33e-07 | 24 | 131 | 5 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 6.63e-07 | 26 | 131 | 5 | GO:0004022 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.41e-06 | 30 | 131 | 5 | GO:0018455 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 1.68e-06 | 14 | 131 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 1.68e-06 | 14 | 131 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 7.90e-06 | 20 | 131 | 4 | GO:0004303 | |
| GeneOntologyMolecularFunction | NADPH binding | 2.36e-05 | 26 | 131 | 4 | GO:0070402 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 2.76e-05 | 27 | 131 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 4.38e-05 | 11 | 131 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 4.60e-05 | 60 | 131 | 5 | GO:0016655 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 5.52e-05 | 32 | 131 | 4 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 6.25e-05 | 33 | 131 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 7.04e-05 | 34 | 131 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 1.22e-04 | 39 | 131 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.35e-04 | 40 | 131 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 2.54e-04 | 4 | 131 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 2.54e-04 | 4 | 131 | 2 | GO:0047696 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 2.75e-04 | 48 | 131 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 4.07e-04 | 95 | 131 | 5 | GO:0016651 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 4.99e-04 | 56 | 131 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 6.49e-04 | 60 | 131 | 4 | GO:0005544 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 7.35e-04 | 62 | 131 | 4 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 7.35e-04 | 62 | 131 | 4 | GO:0050661 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 8.78e-04 | 7 | 131 | 2 | GO:0004703 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 9.71e-04 | 115 | 131 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.17e-03 | 8 | 131 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 1.49e-03 | 9 | 131 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.51e-03 | 127 | 131 | 5 | GO:0016616 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.78e-03 | 194 | 131 | 6 | GO:0016705 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 2.18e-03 | 138 | 131 | 5 | GO:0016614 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 3.00e-03 | 44 | 131 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | 5'-nucleotidase activity | 4.24e-03 | 15 | 131 | 2 | GO:0008253 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 1.33e-09 | 4 | 126 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 1.33e-09 | 4 | 126 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 1.33e-09 | 4 | 126 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 1.33e-09 | 4 | 126 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 3.52e-09 | 11 | 126 | 5 | GO:2000224 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 6.61e-09 | 5 | 126 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 6.61e-09 | 5 | 126 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 6.61e-09 | 5 | 126 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 6.61e-09 | 5 | 126 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 6.61e-09 | 5 | 126 | 4 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 6.61e-09 | 5 | 126 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 1.97e-08 | 6 | 126 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 1.97e-08 | 6 | 126 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 3.25e-08 | 16 | 126 | 5 | GO:0061370 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 4.58e-08 | 7 | 126 | 4 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 4.58e-08 | 7 | 126 | 4 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 4.58e-08 | 7 | 126 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 6.62e-08 | 88 | 126 | 8 | GO:0071277 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 1.48e-07 | 21 | 126 | 5 | GO:0048385 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 1.48e-07 | 21 | 126 | 5 | GO:0042574 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 1.63e-07 | 9 | 126 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | parturition | 1.90e-07 | 22 | 126 | 5 | GO:0007567 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 2.71e-07 | 10 | 126 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 2.71e-07 | 10 | 126 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 2.71e-07 | 10 | 126 | 4 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 2.71e-07 | 10 | 126 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 2.71e-07 | 10 | 126 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 4.24e-07 | 11 | 126 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 4.66e-07 | 26 | 126 | 5 | GO:0010566 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 6.49e-07 | 161 | 126 | 9 | GO:0051592 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 1.27e-06 | 14 | 126 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 1.27e-06 | 14 | 126 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 1.72e-06 | 15 | 126 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.90e-06 | 34 | 126 | 5 | GO:0006706 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 2.20e-06 | 35 | 126 | 5 | GO:0120255 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 2.28e-06 | 16 | 126 | 4 | GO:0032351 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 3.35e-06 | 38 | 126 | 5 | GO:0048384 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 3.80e-06 | 18 | 126 | 4 | GO:0030656 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 5.62e-06 | 73 | 126 | 6 | GO:1901616 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 7.33e-06 | 21 | 126 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 7.33e-06 | 21 | 126 | 4 | GO:0016114 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 7.33e-06 | 21 | 126 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 8.92e-06 | 22 | 126 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 8.92e-06 | 22 | 126 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 8.92e-06 | 22 | 126 | 4 | GO:1902644 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 9.81e-06 | 47 | 126 | 5 | GO:0046164 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 1.07e-05 | 23 | 126 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 1.07e-05 | 23 | 126 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 2.43e-05 | 28 | 126 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 2.55e-05 | 57 | 126 | 5 | GO:0042181 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 2.80e-05 | 29 | 126 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 2.80e-05 | 29 | 126 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 3.28e-05 | 60 | 126 | 5 | GO:1904037 | |
| GeneOntologyBiologicalProcess | response to estrogen | 4.06e-05 | 103 | 126 | 6 | GO:0043627 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 4.18e-05 | 32 | 126 | 4 | GO:2000353 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 4.53e-05 | 105 | 126 | 6 | GO:0006721 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 4.74e-05 | 33 | 126 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | response to metal ion | CPNE2 AKR1C4 CPNE5 AKR1C1 AKR1C2 NEDD4 FGF23 CPNE3 AKR1C3 CPNE4 ABCC2 | 4.90e-05 | 415 | 126 | 11 | GO:0010038 |
| GeneOntologyBiologicalProcess | secondary metabolic process | 5.60e-05 | 67 | 126 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 5.72e-05 | 217 | 126 | 8 | GO:0051897 | |
| GeneOntologyBiologicalProcess | cellular response to metal ion | 6.10e-05 | 219 | 126 | 8 | GO:0071248 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 6.72e-05 | 36 | 126 | 4 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 6.72e-05 | 36 | 126 | 4 | GO:0008299 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.02e-04 | 40 | 126 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 1.21e-04 | 180 | 126 | 7 | GO:0120254 | |
| GeneOntologyBiologicalProcess | endothelial cell apoptotic process | 1.23e-04 | 79 | 126 | 5 | GO:0072577 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 1.24e-04 | 42 | 126 | 4 | GO:0071398 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 1.63e-04 | 45 | 126 | 4 | GO:0008207 | |
| GeneOntologyBiologicalProcess | response to ketone | 1.70e-04 | 254 | 126 | 8 | GO:1901654 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 2.16e-04 | 89 | 126 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | positive regulation of cholangiocyte proliferation | 2.20e-04 | 4 | 126 | 2 | GO:1904056 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 2.31e-04 | 141 | 126 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 2.40e-04 | 91 | 126 | 5 | GO:0051055 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | TRAF6 HDAC6 AKR1C4 AKR1C1 AKR1C2 CARD8 NEDD4 AKR1C3 CNOT1 LILRA4 | 2.41e-04 | 416 | 126 | 10 | GO:0030522 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 2.46e-04 | 202 | 126 | 7 | GO:0141193 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 2.58e-04 | 144 | 126 | 6 | GO:0006720 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 2.79e-04 | 94 | 126 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 2.93e-04 | 95 | 126 | 5 | GO:0006081 | |
| GeneOntologyBiologicalProcess | glycosyl compound metabolic process | 3.08e-04 | 96 | 126 | 5 | GO:1901657 | |
| GeneOntologyBiologicalProcess | neuron intrinsic apoptotic signaling pathway in response to oxidative stress | 3.15e-04 | 22 | 126 | 3 | GO:0036480 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 3.81e-04 | 56 | 126 | 4 | GO:0006693 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 4.08e-04 | 57 | 126 | 4 | GO:0006692 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 4.36e-04 | 58 | 126 | 4 | GO:0032350 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 4.55e-04 | 294 | 126 | 8 | GO:0044706 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 4.86e-04 | 106 | 126 | 5 | GO:0034308 | |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 4.86e-04 | 106 | 126 | 5 | GO:0050810 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | TRAF6 HDAC6 SASH1 AKR1C4 AKR1C1 AKR1C2 CARD8 NEDD4 FGF23 AKR1C3 CD68 MMP2 CNOT1 | 6.68e-04 | 748 | 126 | 13 | GO:0071396 |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 6.74e-04 | 239 | 126 | 7 | GO:0071383 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 7.05e-04 | 115 | 126 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 7.62e-04 | 244 | 126 | 7 | GO:0009755 | |
| GeneOntologyBiologicalProcess | regulation of lipopolysaccharide-mediated signaling pathway | 8.01e-04 | 30 | 126 | 3 | GO:0031664 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 8.45e-04 | 69 | 126 | 4 | GO:0070542 | |
| GeneOntologyBiologicalProcess | regulation of cholangiocyte proliferation | 1.01e-03 | 8 | 126 | 2 | GO:1904054 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1.04e-03 | 334 | 126 | 8 | GO:0051896 | |
| GeneOntologyBiologicalProcess | regulation of ketone metabolic process | 1.08e-03 | 189 | 126 | 6 | GO:0010565 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell apoptotic process | 1.10e-03 | 74 | 126 | 4 | GO:2000351 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 1.14e-03 | 421 | 126 | 9 | GO:0044282 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 1.14e-03 | 128 | 126 | 5 | GO:0033559 | |
| GeneOntologyBiologicalProcess | epithelial cell apoptotic process | 1.18e-03 | 192 | 126 | 6 | GO:1904019 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | HDAC6 APLP1 AKR1C4 SIN3A AKR1C1 AKR1C2 NEDD4 FGF23 AKR1C3 MMP2 CNOT1 | 1.22e-03 | 605 | 126 | 11 | GO:0071407 |
| MousePheno | parturition failure | 5.21e-07 | 10 | 101 | 4 | MP:0012010 | |
| MousePheno | hypermyelination | 8.15e-07 | 11 | 101 | 4 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 1.75e-06 | 13 | 101 | 4 | MP:0010160 | |
| MousePheno | increased circulating progesterone level | 3.30e-06 | 15 | 101 | 4 | MP:0005186 | |
| MousePheno | long stride length | 3.30e-06 | 15 | 101 | 4 | MP:0010540 | |
| MousePheno | long gestation period | 3.30e-06 | 15 | 101 | 4 | MP:0002293 | |
| MousePheno | abnormal gestational length | 7.27e-06 | 18 | 101 | 4 | MP:0002292 | |
| MousePheno | dysmyelination | 1.14e-05 | 20 | 101 | 4 | MP:0013438 | |
| MousePheno | decreased oligodendrocyte number | 2.89e-05 | 25 | 101 | 4 | MP:0009808 | |
| MousePheno | prolonged diestrus | 6.09e-05 | 30 | 101 | 4 | MP:0009011 | |
| MousePheno | abnormal parturition | 8.94e-05 | 33 | 101 | 4 | MP:0002907 | |
| MousePheno | abnormal diestrus | 1.13e-04 | 35 | 101 | 4 | MP:0009010 | |
| MousePheno | enhanced coordination | 1.57e-04 | 38 | 101 | 4 | MP:0003858 | |
| MousePheno | prolonged estrous cycle | 1.74e-04 | 39 | 101 | 4 | MP:0009006 | |
| MousePheno | decreased vocalization | 3.32e-04 | 46 | 101 | 4 | MP:0020351 | |
| Domain | Copine | 2.50e-07 | 9 | 127 | 4 | PF07002 | |
| Domain | Copine | 2.50e-07 | 9 | 127 | 4 | IPR010734 | |
| Domain | ALDOKETO_REDUCTASE_1 | 4.15e-07 | 10 | 127 | 4 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 4.15e-07 | 10 | 127 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 4.15e-07 | 10 | 127 | 4 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 4.15e-07 | 10 | 127 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 4.15e-07 | 10 | 127 | 4 | IPR020471 | |
| Domain | MORN | 2.63e-06 | 15 | 127 | 4 | IPR003409 | |
| Domain | MORN | 2.63e-06 | 15 | 127 | 4 | PF02493 | |
| Domain | - | 3.48e-06 | 16 | 127 | 4 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 4.53e-06 | 17 | 127 | 4 | IPR023210 | |
| Domain | Aldo_ket_red | 4.53e-06 | 17 | 127 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 4.53e-06 | 17 | 127 | 4 | IPR001395 | |
| Domain | VWFA | 2.01e-05 | 82 | 127 | 6 | PS50234 | |
| Domain | VWA | 2.31e-05 | 84 | 127 | 6 | SM00327 | |
| Domain | VWF_A | 5.87e-05 | 99 | 127 | 6 | IPR002035 | |
| Domain | MORN | 1.06e-04 | 14 | 127 | 3 | SM00698 | |
| Domain | HAD-SF_hydro_IG_5-nucl | 2.73e-04 | 4 | 127 | 2 | IPR008380 | |
| Domain | 5_nucleotid | 2.73e-04 | 4 | 127 | 2 | PF05761 | |
| Domain | C2 | 2.74e-04 | 131 | 127 | 6 | PF00168 | |
| Domain | C2 | 3.49e-04 | 137 | 127 | 6 | SM00239 | |
| Domain | C2 | 4.23e-04 | 142 | 127 | 6 | PS50004 | |
| Domain | DOCK_N | 4.53e-04 | 5 | 127 | 2 | PF16172 | |
| Domain | DOCK_N | 4.53e-04 | 5 | 127 | 2 | IPR032376 | |
| Domain | - | 5.26e-04 | 148 | 127 | 6 | 2.60.40.150 | |
| Domain | C2_dom | 9.01e-04 | 164 | 127 | 6 | IPR000008 | |
| Domain | GPCR_kinase | 9.42e-04 | 7 | 127 | 2 | IPR000239 | |
| Domain | - | 1.62e-03 | 74 | 127 | 4 | 3.40.50.410 | |
| Domain | DHR-1_domain | 2.42e-03 | 11 | 127 | 2 | IPR027007 | |
| Domain | DHR_2 | 2.42e-03 | 11 | 127 | 2 | PS51651 | |
| Domain | DHR_1 | 2.42e-03 | 11 | 127 | 2 | PS51650 | |
| Domain | DHR-2 | 2.42e-03 | 11 | 127 | 2 | PF06920 | |
| Domain | DOCK | 2.42e-03 | 11 | 127 | 2 | IPR026791 | |
| Domain | DOCK_C | 2.42e-03 | 11 | 127 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 2.42e-03 | 11 | 127 | 2 | PF14429 | |
| Domain | DHR-2 | 2.42e-03 | 11 | 127 | 2 | IPR027357 | |
| Domain | ZnF_UBP | 2.42e-03 | 11 | 127 | 2 | SM00290 | |
| Domain | SET | 2.71e-03 | 41 | 127 | 3 | PF00856 | |
| Domain | CarboxyPept_regulatory_dom | 3.41e-03 | 13 | 127 | 2 | IPR014766 | |
| Domain | NCD3G | 3.41e-03 | 13 | 127 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 3.41e-03 | 13 | 127 | 2 | IPR011500 | |
| Domain | - | 3.41e-03 | 13 | 127 | 2 | 2.60.40.1120 | |
| Domain | SET | 3.77e-03 | 46 | 127 | 3 | SM00317 | |
| Domain | Znf_UBP | 3.96e-03 | 14 | 127 | 2 | IPR001607 | |
| Domain | zf-UBP | 3.96e-03 | 14 | 127 | 2 | PF02148 | |
| Domain | ZF_UBP | 3.96e-03 | 14 | 127 | 2 | PS50271 | |
| Domain | GPCR_3_CS | 3.96e-03 | 14 | 127 | 2 | IPR017979 | |
| Domain | SET_dom | 4.77e-03 | 50 | 127 | 3 | IPR001214 | |
| Domain | SET | 4.77e-03 | 50 | 127 | 3 | PS50280 | |
| Domain | Post-SET_dom | 5.17e-03 | 16 | 127 | 2 | IPR003616 | |
| Domain | PostSET | 5.17e-03 | 16 | 127 | 2 | SM00508 | |
| Domain | POST_SET | 5.17e-03 | 16 | 127 | 2 | PS50868 | |
| Domain | CarboxyPept-like_regulatory | 5.84e-03 | 17 | 127 | 2 | IPR008969 | |
| Domain | Zn_pept | 6.54e-03 | 18 | 127 | 2 | SM00631 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 1.74e-07 | 9 | 88 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 1.74e-07 | 9 | 88 | 4 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 4.52e-07 | 11 | 88 | 4 | M47812 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 7.42e-07 | 28 | 88 | 5 | MM15188 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 9.71e-07 | 13 | 88 | 4 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 9.71e-07 | 13 | 88 | 4 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 1.35e-06 | 14 | 88 | 4 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.35e-06 | 14 | 88 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 1.35e-06 | 14 | 88 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.35e-06 | 14 | 88 | 4 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 1.84e-06 | 15 | 88 | 4 | MM14870 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.15e-05 | 23 | 88 | 4 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.15e-05 | 23 | 88 | 4 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.15e-05 | 23 | 88 | 4 | MM14741 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.30e-05 | 49 | 88 | 5 | MM15186 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 5.05e-05 | 33 | 88 | 4 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 5.05e-05 | 33 | 88 | 4 | MM14737 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 7.43e-05 | 70 | 88 | 5 | M16794 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.59e-04 | 44 | 88 | 4 | M499 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.74e-04 | 45 | 88 | 4 | MM15344 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.74e-04 | 45 | 88 | 4 | MM14751 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.89e-04 | 191 | 88 | 7 | MM15586 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 3.79e-04 | 55 | 88 | 4 | M14933 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 5.64e-04 | 61 | 88 | 4 | MM14861 | |
| Pathway | REACTOME_DRUG_ADME | 8.83e-04 | 119 | 88 | 5 | MM15692 | |
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 1.92e-10 | 4 | 131 | 4 | 10500239 | |
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 1.92e-10 | 4 | 131 | 4 | 14967952 | |
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 1.92e-10 | 4 | 131 | 4 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 1.92e-10 | 4 | 131 | 4 | 31479646 | |
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 16191478 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 15577209 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 10702227 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 1.92e-10 | 4 | 131 | 4 | 29764944 | |
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 17888864 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 17442338 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 28329705 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 19237748 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 28259989 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 16511129 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 7789999 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 1.92e-10 | 4 | 131 | 4 | 16508162 | |
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 15222881 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 17629694 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 10526179 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 16018803 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 1.92e-10 | 4 | 131 | 4 | 18667791 | |
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 21521174 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 8274401 | ||
| Pubmed | 1.92e-10 | 4 | 131 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 1.92e-10 | 4 | 131 | 4 | 34590152 | |
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 9.58e-10 | 5 | 131 | 4 | 21851338 | |
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 9.58e-10 | 5 | 131 | 4 | 16984997 | |
| Pubmed | 9.58e-10 | 5 | 131 | 4 | 7737980 | ||
| Pubmed | 9.58e-10 | 5 | 131 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 9.58e-10 | 5 | 131 | 4 | 17064890 | |
| Pubmed | 9.58e-10 | 5 | 131 | 4 | 10672042 | ||
| Pubmed | 9.58e-10 | 5 | 131 | 4 | 38788959 | ||
| Pubmed | 9.58e-10 | 5 | 131 | 4 | 18003893 | ||
| Pubmed | 2.87e-09 | 6 | 131 | 4 | 19273550 | ||
| Pubmed | 2.87e-09 | 6 | 131 | 4 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 2.87e-09 | 6 | 131 | 4 | 26748576 | |
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 2.87e-09 | 6 | 131 | 4 | 29107092 | |
| Pubmed | 2.87e-09 | 6 | 131 | 4 | 15860270 | ||
| Pubmed | 2.87e-09 | 6 | 131 | 4 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 2.87e-09 | 6 | 131 | 4 | 17255200 | |
| Pubmed | 6.67e-09 | 7 | 131 | 4 | 22529366 | ||
| Pubmed | 6.67e-09 | 7 | 131 | 4 | 33127481 | ||
| Pubmed | 6.67e-09 | 7 | 131 | 4 | 12562828 | ||
| Pubmed | 6.67e-09 | 7 | 131 | 4 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 6.67e-09 | 7 | 131 | 4 | 34843575 | |
| Pubmed | 6.67e-09 | 7 | 131 | 4 | 16337335 | ||
| Pubmed | 1.33e-08 | 8 | 131 | 4 | 33584538 | ||
| Pubmed | 1.33e-08 | 8 | 131 | 4 | 9224647 | ||
| Pubmed | 1.33e-08 | 8 | 131 | 4 | 20837989 | ||
| Pubmed | 2.39e-08 | 9 | 131 | 4 | 9430674 | ||
| Pubmed | 2.39e-08 | 9 | 131 | 4 | 33348080 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 3.97e-08 | 10 | 131 | 4 | 36313771 | |
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 5.22e-08 | 3 | 131 | 3 | 31780644 | |
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 13678667 | ||
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 7626489 | ||
| Pubmed | 5.22e-08 | 3 | 131 | 3 | 21232532 | ||
| Pubmed | 9.30e-08 | 12 | 131 | 4 | 25774556 | ||
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 9.30e-08 | 12 | 131 | 4 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 9.30e-08 | 12 | 131 | 4 | 28893949 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 11682476 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 1.34e-07 | 13 | 131 | 4 | 15117747 | |
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 24580729 | ||
| Pubmed | 1.34e-07 | 13 | 131 | 4 | 17062636 | ||
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 1.87e-07 | 14 | 131 | 4 | 34400844 | |
| Pubmed | 2.78e-07 | 37 | 131 | 5 | 21362171 | ||
| Pubmed | 4.40e-07 | 17 | 131 | 4 | 32243503 | ||
| Pubmed | 5.19e-07 | 5 | 131 | 3 | 15212687 | ||
| Pubmed | Functional dynamics of H3K9 methylation during meiotic prophase progression. | 7.13e-07 | 19 | 131 | 4 | 17599069 | |
| Pubmed | 8.89e-07 | 20 | 131 | 4 | 24135228 | ||
| Pubmed | 8.89e-07 | 20 | 131 | 4 | 23636947 | ||
| Pubmed | 9.49e-07 | 47 | 131 | 5 | 11208732 | ||
| Pubmed | 1.58e-06 | 52 | 131 | 5 | 23260145 | ||
| Pubmed | 1.61e-06 | 23 | 131 | 4 | 23685333 | ||
| Pubmed | 1.81e-06 | 7 | 131 | 3 | 19846565 | ||
| Pubmed | Foxl2 functions in sex determination and histogenesis throughout mouse ovary development. | 2.10e-06 | 55 | 131 | 5 | 19538736 | |
| Pubmed | 2.29e-06 | 25 | 131 | 4 | 26098214 | ||
| Pubmed | Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis. | 2.69e-06 | 26 | 131 | 4 | 23892084 | |
| Pubmed | 3.15e-06 | 27 | 131 | 4 | 17077188 | ||
| Pubmed | 3.15e-06 | 27 | 131 | 4 | 23471215 | ||
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 3.15e-06 | 27 | 131 | 4 | 14581517 | |
| Pubmed | The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion. | 3.67e-06 | 28 | 131 | 4 | 29212953 | |
| Pubmed | MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. | 3.67e-06 | 28 | 131 | 4 | 29879378 | |
| Pubmed | 3.67e-06 | 28 | 131 | 4 | 21820362 | ||
| Pubmed | SASH1 NSD2 HEPH SLC38A2 KMT2C AGO4 NUAK1 SYNJ2 SETD7 CNOT1 MGRN1 | 5.58e-06 | 529 | 131 | 11 | 14621295 | |
| Pubmed | 6.37e-06 | 32 | 131 | 4 | 34288113 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 8573067 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 15492289 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 26350878 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 32214906 | ||
| Pubmed | Nedd4 E3 ubiquitin ligase promotes cell proliferation and autophagy. | 1.41e-05 | 2 | 131 | 2 | 25809873 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 30367463 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 21217827 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 8486699 | ||
| Interaction | AKR1C4 interactions | 1.10e-07 | 8 | 129 | 4 | int:AKR1C4 | |
| Interaction | AKR1C3 interactions | 3.68e-06 | 37 | 129 | 5 | int:AKR1C3 | |
| Interaction | AKR1C1 interactions | 7.17e-06 | 20 | 129 | 4 | int:AKR1C1 | |
| Cytoband | 10p15-p14 | 4.51e-07 | 6 | 131 | 3 | 10p15-p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 1.34e-04 | 90 | 131 | 4 | chr10p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q15 | 5.64e-04 | 56 | 131 | 3 | chr12q15 | |
| GeneFamily | Copines | 4.18e-08 | 9 | 79 | 4 | 829 | |
| GeneFamily | Aldo-keto reductases | 4.44e-07 | 15 | 79 | 4 | 399 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.36e-04 | 34 | 79 | 3 | 487 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 1.64e-08 | 17 | 130 | 5 | MM826 | |
| Coexpression | ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF | ENTPD7 TRAF6 GRK6 FNBP1L NT5DC3 NEDD4 DOCK5 SLC38A2 AGO4 SYNJ2 ADAMTS15 SIPA1L2 SDR16C5 CNN3 DOP1A | 1.03e-07 | 550 | 130 | 15 | M2611 |
| Coexpression | GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP | 7.00e-07 | 146 | 130 | 8 | M8904 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 1.16e-06 | 156 | 130 | 8 | MM550 | |
| Coexpression | VARELA_ZMPSTE24_TARGETS_DN | 2.89e-06 | 45 | 130 | 5 | MM1173 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 5.68e-06 | 24 | 130 | 4 | MM766 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 6.74e-06 | 25 | 130 | 4 | MM480 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN | 7.32e-06 | 200 | 130 | 8 | M8962 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 1.43e-05 | 30 | 130 | 4 | MM853 | |
| Coexpression | NADLER_HYPERGLYCEMIA_AT_OBESITY | 1.95e-05 | 66 | 130 | 5 | MM631 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.96e-05 | 111 | 130 | 6 | MM705 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 2.42e-05 | 69 | 130 | 5 | MM621 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 3.01e-05 | 36 | 130 | 4 | MM3660 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP | 3.36e-05 | 37 | 130 | 4 | M1367 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 3.36e-05 | 37 | 130 | 4 | MM630 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP | 3.74e-05 | 38 | 130 | 4 | MM782 | |
| Coexpression | PEDRIOLI_MIR31_TARGETS_DN | DOCK1 CWF19L2 PADI4 MAN2C1 CPM DCAF12L2 AKR1C1 AKR1C2 NUDT6 VAT1 | 4.20e-05 | 413 | 130 | 10 | M2494 |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 | 4.67e-05 | 79 | 130 | 5 | MM535 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP | 6.49e-05 | 200 | 130 | 7 | M6649 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_UP | 6.49e-05 | 200 | 130 | 7 | M3584 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 8.81e-05 | 210 | 130 | 7 | MM958 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-06 | 185 | 130 | 7 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | COVID-19-kidney-Stressed_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.51e-06 | 191 | 130 | 7 | d35aa842b813ea0eff7362abc894cca4e86b2fb2 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 193 | 130 | 7 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 193 | 130 | 7 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 193 | 130 | 7 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 200 | 130 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | CD8+_Memory_T_cell-FLU-1|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.19e-06 | 162 | 130 | 6 | 76f39935763848ea6e7917b2f9f1432c543063d9 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 8.79e-06 | 164 | 130 | 6 | 81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 172 | 130 | 6 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 172 | 130 | 6 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-05 | 174 | 130 | 6 | 4a18b51501eaaeb7907e99316ba8ae15b2c7d529 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 180 | 130 | 6 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 180 | 130 | 6 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 180 | 130 | 6 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 180 | 130 | 6 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.59e-05 | 182 | 130 | 6 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-05 | 186 | 130 | 6 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-05 | 186 | 130 | 6 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 1.85e-05 | 187 | 130 | 6 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 188 | 130 | 6 | 5b69de5baaac45a6d4daa1dbfcb70a7b2ae744ac | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 189 | 130 | 6 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 1.97e-05 | 189 | 130 | 6 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 189 | 130 | 6 | 25db316f66cee53774bb2b286cc457b37353356c | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 190 | 130 | 6 | dc7e92f1b18d0f5efec11d09d56ba954d4f8b3bd | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-05 | 190 | 130 | 6 | 32400c62cb9de4c2b24af4206c21a0215ab12212 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 190 | 130 | 6 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 190 | 130 | 6 | 0bb06df3d5a50416854370f234718c6cec3d773b | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 190 | 130 | 6 | 008290bb5c79446681dd6bf354336c57ad0d6f13 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 190 | 130 | 6 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-05 | 190 | 130 | 6 | b2bd2cb384bb8a5662064ed1aee68e905e1f780d | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 190 | 130 | 6 | 3720e64129f3f3268b1dc14031a76f41c38241c2 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 190 | 130 | 6 | 73a50426f972f08f9bb525ad5c0b774187ab5d6a | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 190 | 130 | 6 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 190 | 130 | 6 | b55cf1fb586b724295b7b038483249847bb344fc | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 190 | 130 | 6 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 190 | 130 | 6 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | droplet-Mammary_Gland-nan-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 191 | 130 | 6 | 8022059e434fd411dc539819f969bd4f94861281 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 191 | 130 | 6 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 191 | 130 | 6 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.09e-05 | 191 | 130 | 6 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 191 | 130 | 6 | 7411b253b16e4d472be0925dee49188f0fd6b0b5 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 192 | 130 | 6 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-05 | 192 | 130 | 6 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 192 | 130 | 6 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-05 | 192 | 130 | 6 | fb0d05a2c83816794652a6e5af8713e9bb22d5db | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 192 | 130 | 6 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-05 | 192 | 130 | 6 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | facs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-05 | 192 | 130 | 6 | e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 2.21e-05 | 193 | 130 | 6 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 194 | 130 | 6 | 14b614f039bc866a1348a2728a68b7d254c7748c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 194 | 130 | 6 | 68c7bfead1158641928cc276f599b4a79e06c73c | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 194 | 130 | 6 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.28e-05 | 194 | 130 | 6 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 194 | 130 | 6 | f6aeae6a1e4017e341323fd4784c9e3bae00552b | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-05 | 194 | 130 | 6 | 889c6e231bdd5b59902c7d2afdc077360b1d3256 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 2.34e-05 | 195 | 130 | 6 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 2.34e-05 | 195 | 130 | 6 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 195 | 130 | 6 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | facs-Trachea-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.34e-05 | 195 | 130 | 6 | 0d1876f6fdc1eafeb60d6fd7da5bce737d2b4a5a | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.41e-05 | 196 | 130 | 6 | 9e737eaa98fd49972fce64d1d4a4d1f34b9bcb96 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 196 | 130 | 6 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 196 | 130 | 6 | 65f2f51e17f1869f3468813127b96d3048d8ad41 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 196 | 130 | 6 | e4ed897900a6472738bc6be2fb4817192727225d | |
| ToppCell | droplet-Lung-30m-Endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.41e-05 | 196 | 130 | 6 | 58871891185aa7e1e4ab9b99cd25c1ca3c932cc8 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-05 | 196 | 130 | 6 | 48f7516129570981846c667a07abe5a9abe62dcd | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 196 | 130 | 6 | 2cd83176f2e8a9e6fa3c08cb33928a61e5fc43b6 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 196 | 130 | 6 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.41e-05 | 196 | 130 | 6 | 99a7f2e57774884216525897dcd32a289107548b | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.41e-05 | 196 | 130 | 6 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.48e-05 | 197 | 130 | 6 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | tumor_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.48e-05 | 197 | 130 | 6 | a05237ee6d31d9eab491dd7007859d6285cf1424 | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.55e-05 | 198 | 130 | 6 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-05 | 199 | 130 | 6 | beca4c7eb29ac771fd37f30cd23d4dce4afcfff8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-05 | 199 | 130 | 6 | 8766796041965a1ba40ad7abdbc244bf1418c209 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | 7ed541309808f15d65a9c4b26be2050e077539e6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-05 | 199 | 130 | 6 | cd3ab9a75b40e0d417d53b3d8756fc9bed30ac83 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | 6f5ef959b51eccf1ffc2e5ddf0d83c62ca2257b2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | 1aa99d21bf61b86df4a966dc47634044430aa39f | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.63e-05 | 199 | 130 | 6 | 97052c28e354833901f28d339b09f97f50a5b752 | |
| ToppCell | NS-moderate-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.63e-05 | 199 | 130 | 6 | aa2b51940115c22768c0d7493b4b60d41df3f376 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-05 | 199 | 130 | 6 | d39b40d84c72bdde756b805063317ecfad3784f8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | 2989325b0e78ab42f362cfb59e34a4fce7f8e869 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Cortical_neuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.70e-05 | 200 | 130 | 6 | 085060d148158f7d9e938b6c4a3700ccbb3bca15 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-05 | 200 | 130 | 6 | 2554b77edfe3d378296b0b25625caacbfb1c0e76 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 2.70e-05 | 200 | 130 | 6 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.70e-05 | 200 | 130 | 6 | 9b5753726c17dda98d7384a60f26a5eaf4f6c4d6 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.89e-05 | 150 | 130 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 9.78e-05 | 157 | 130 | 5 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 159 | 130 | 5 | 9f6607e395bcca9cb1c83199bdbbaaa62a93938d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 159 | 130 | 5 | c8b42ebc25ebcc450832096fbffaa5c5f5fe88e7 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 162 | 130 | 5 | 22f1abd20f43bc7e7fc46969da9962faf70ae5d2 | |
| Drug | cloxazolam | 9.84e-10 | 4 | 129 | 4 | ctd:C005522 | |
| Drug | Pregnanes | 9.84e-10 | 4 | 129 | 4 | ctd:D011278 | |
| Drug | tetralol | 9.84e-10 | 4 | 129 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 9.84e-10 | 4 | 129 | 4 | ctd:C018156 | |
| Drug | Hydroxysteroids | 4.90e-09 | 5 | 129 | 4 | ctd:D006914 | |
| Drug | cresolphthalein | 4.90e-09 | 5 | 129 | 4 | ctd:C010092 | |
| Drug | Glipizide | 1.46e-08 | 6 | 129 | 4 | ctd:D005913 | |
| Drug | Medazepam | 1.46e-08 | 6 | 129 | 4 | ctd:D008472 | |
| Drug | Nitrazepam | 6.76e-08 | 8 | 129 | 4 | ctd:D009567 | |
| Drug | 4-hydroxybenzoic acid | 1.21e-07 | 9 | 129 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 1.21e-07 | 9 | 129 | 4 | ctd:D004092 | |
| Drug | cyclopentanol | 1.78e-07 | 3 | 129 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 1.78e-07 | 3 | 129 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 1.78e-07 | 3 | 129 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 1.78e-07 | 3 | 129 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 1.78e-07 | 3 | 129 | 3 | ctd:C530610 | |
| Drug | octyl gallate | 2.01e-07 | 10 | 129 | 4 | ctd:C016627 | |
| Drug | Glycyrrhetinic Acid | 2.11e-07 | 24 | 129 | 5 | ctd:D006034 | |
| Drug | 9,10-phenanthrenequinone | 2.62e-07 | 25 | 129 | 5 | ctd:C005399 | |
| Drug | Dihydroxydihydrobenzopyrenes | 3.15e-07 | 11 | 129 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 3.15e-07 | 11 | 129 | 4 | CID000013946 | |
| Drug | Phenolphthalein | 4.70e-07 | 12 | 129 | 4 | ctd:D020113 | |
| Drug | DMBA-3,4-dihydrodiol | 6.76e-07 | 13 | 129 | 4 | CID000050096 | |
| Drug | flunisolide | 6.76e-07 | 13 | 129 | 4 | ctd:C007734 | |
| Drug | tetrahydrodeoxycorticosterone | 7.08e-07 | 4 | 129 | 3 | ctd:C009413 | |
| Drug | gliquidone | 7.08e-07 | 4 | 129 | 3 | ctd:C010969 | |
| Drug | DBD-H | 7.08e-07 | 4 | 129 | 3 | CID000131382 | |
| Drug | 5-alpha-Dihydroprogesterone | 9.42e-07 | 14 | 129 | 4 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 9.42e-07 | 14 | 129 | 4 | CID000022750 | |
| Drug | Meclofenamic Acid | 9.42e-07 | 14 | 129 | 4 | ctd:D008469 | |
| Drug | NSC86000 | 1.76e-06 | 5 | 129 | 3 | CID000257630 | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; PC3; HG-U133A | 1.98e-06 | 198 | 129 | 9 | 1900_DN | |
| Drug | AC1L93E5 | 3.51e-06 | 6 | 129 | 3 | CID000412383 | |
| Drug | Estazolam | 3.51e-06 | 6 | 129 | 3 | ctd:D004949 | |
| Drug | 3-hydroxyhexobarbital | 3.51e-06 | 6 | 129 | 3 | CID000439898 | |
| Drug | acenaphthene-1-ol | 3.51e-06 | 6 | 129 | 3 | ctd:C023723 | |
| Drug | oxcarbazepine | 3.57e-06 | 19 | 129 | 4 | ctd:C036006 | |
| Drug | benzo(a)pyrene-7,8-dione | 4.44e-06 | 20 | 129 | 4 | ctd:C076588 | |
| Drug | Chrysenes | 4.44e-06 | 20 | 129 | 4 | ctd:D002911 | |
| Drug | Flunitrazepam | 5.46e-06 | 21 | 129 | 4 | ctd:D005445 | |
| Drug | coniferaldehyde | 5.46e-06 | 21 | 129 | 4 | ctd:C075384 | |
| Drug | naphthalene-1,2-dihydrodiol | 5.50e-06 | 45 | 129 | 5 | CID000000362 | |
| Drug | 4-hydroxyequilenin-o-quinone | 6.12e-06 | 7 | 129 | 3 | ctd:C117714 | |
| Drug | zomepirac | 6.12e-06 | 7 | 129 | 3 | ctd:C020549 | |
| Drug | benzene dihydrodiol | 6.65e-06 | 22 | 129 | 4 | CID000000418 | |
| Drug | 2-cyclohexen-1-ol | 9.75e-06 | 8 | 129 | 3 | CID000013198 | |
| Drug | Pregnanolone | 1.13e-05 | 25 | 129 | 4 | ctd:D011280 | |
| Drug | (+,-)-Synephrine [94-07-5]; Down 200; 24uM; MCF7; HT_HG-U133A | 1.76e-05 | 198 | 129 | 8 | 3578_DN | |
| Drug | 1,2-dihydroxynaphthalene | 1.79e-05 | 57 | 129 | 5 | CID000011318 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 2.75e-05 | 31 | 129 | 4 | ctd:C017228 | |
| Drug | 7-hydroxyflavone | 2.84e-05 | 11 | 129 | 3 | ctd:C429845 | |
| Drug | alpha-methylcinnamic acid | 3.19e-05 | 2 | 129 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 3.19e-05 | 2 | 129 | 2 | DB07768 | |
| Drug | baccharin | 3.19e-05 | 2 | 129 | 2 | ctd:C012764 | |
| Drug | fenamic acid | 3.77e-05 | 12 | 129 | 3 | ctd:C001209 | |
| Drug | 4-formyl-benzoate | 4.88e-05 | 13 | 129 | 3 | CID000012088 | |
| Drug | quercitrin | 5.03e-05 | 36 | 129 | 4 | CID005280459 | |
| Drug | dapsone | 5.96e-05 | 73 | 129 | 5 | CID000002955 | |
| Drug | Dydrogesterone | 6.18e-05 | 14 | 129 | 3 | ctd:D004394 | |
| Drug | 6-.beta.-Naltrexol | 6.18e-05 | 14 | 129 | 3 | CID000631219 | |
| Drug | Mefenamic Acid | 6.94e-05 | 39 | 129 | 4 | ctd:D008528 | |
| Drug | 20 alpha-dihydroprogesterone | 7.67e-05 | 40 | 129 | 4 | CID000008956 | |
| Drug | drospirenone | 7.69e-05 | 15 | 129 | 3 | ctd:C035144 | |
| Drug | o-quinone | 8.47e-05 | 41 | 129 | 4 | CID000011421 | |
| Drug | 9-cis-retinal | 9.43e-05 | 16 | 129 | 3 | ctd:C031390 | |
| Drug | benzo(a)pyrene-1,6-quinone | 1.14e-04 | 17 | 129 | 3 | ctd:C030233 | |
| Drug | Flufenamic Acid | 1.22e-04 | 45 | 129 | 4 | ctd:D005439 | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.30e-04 | 196 | 129 | 7 | 7025_UP | |
| Drug | Iron, Dietary | 1.33e-04 | 46 | 129 | 4 | ctd:D019266 | |
| Drug | Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.34e-04 | 197 | 129 | 7 | 7021_UP | |
| Drug | cloxazolam | 1.36e-04 | 18 | 129 | 3 | CID000002816 | |
| Drug | Ruthenium Compounds | 1.36e-04 | 18 | 129 | 3 | ctd:D017975 | |
| Drug | benzo(a)pyrene-3,6-quinone | 1.36e-04 | 18 | 129 | 3 | ctd:C018003 | |
| Drug | Diflunisal [22494-42-4]; Down 200; 16uM; PC3; HG-U133A | 1.38e-04 | 198 | 129 | 7 | 1908_DN | |
| Drug | STOCK1N-28457; Up 200; 20uM; MCF7; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 6906_UP | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 4982_UP | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.47e-04 | 200 | 129 | 7 | 7156_UP | |
| Drug | pantoprazole | 1.61e-04 | 19 | 129 | 3 | ctd:C064276 | |
| Drug | pipenzolate | 1.61e-04 | 19 | 129 | 3 | CID000004832 | |
| Drug | AC1L8ZBW | 1.61e-04 | 19 | 129 | 3 | CID000435356 | |
| Drug | 3-pentanone | 1.61e-04 | 19 | 129 | 3 | CID000007288 | |
| Drug | androstane-3,17-dione | 2.00e-04 | 51 | 129 | 4 | CID000000443 | |
| Drug | Dutasteride | 2.19e-04 | 21 | 129 | 3 | ctd:D000068538 | |
| Drug | TPGS | 2.19e-04 | 21 | 129 | 3 | CID000071406 | |
| Disease | Neoplasms, Hormone-Dependent | 7.79e-08 | 3 | 127 | 3 | C0027661 | |
| Disease | Hermaphroditism | 7.74e-07 | 5 | 127 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 7.74e-07 | 5 | 127 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 7.74e-07 | 5 | 127 | 3 | C0033804 | |
| Disease | Intersex Conditions | 7.74e-07 | 5 | 127 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 7.74e-07 | 5 | 127 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 2.69e-06 | 7 | 127 | 3 | C0036875 | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 1.84e-05 | 2 | 127 | 2 | C1839840 | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 1.84e-05 | 2 | 127 | 2 | cv:C1839840 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 1.84e-05 | 2 | 127 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | 46,XY SEX REVERSAL 8 | 1.84e-05 | 2 | 127 | 2 | 614279 | |
| Disease | Rheumatoid Arthritis | 1.11e-04 | 174 | 127 | 6 | C0003873 | |
| Disease | laryngeal carcinoma (is_marker_for) | 2.73e-04 | 6 | 127 | 2 | DOID:2600 (is_marker_for) | |
| Disease | cortolone glucuronide (1) measurement | 2.73e-04 | 6 | 127 | 2 | EFO_0800552 | |
| Disease | parathyroid hormone-related protein measurement | 2.73e-04 | 6 | 127 | 2 | EFO_0020622 | |
| Disease | glycocholenate sulfate measurement | 2.73e-04 | 6 | 127 | 2 | EFO_0800276 | |
| Disease | N6-acetyllysine measurement | 8.09e-04 | 10 | 127 | 2 | EFO_0800036 | |
| Disease | vascular endothelial growth factor D measurement | 9.86e-04 | 11 | 127 | 2 | EFO_0010575 | |
| Disease | Alcoholic Intoxication, Chronic | 1.10e-03 | 268 | 127 | 6 | C0001973 | |
| Disease | rotator cuff tear | 1.18e-03 | 12 | 127 | 2 | EFO_1001250 | |
| Disease | free androgen index | 1.21e-03 | 374 | 127 | 7 | EFO_0007005 | |
| Disease | tryptophan measurement | 1.24e-03 | 49 | 127 | 3 | EFO_0008534 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.39e-03 | 13 | 127 | 2 | EFO_0800474 | |
| Disease | platelet component distribution width | GRK5 SIN3A SLC43A3 DOCK5 SYNJ2 DHPS ZBTB10 CD68 ANTXR1 C4BPA | 1.62e-03 | 755 | 127 | 10 | EFO_0007984 |
| Disease | vascular dementia (biomarker_via_orthology) | 1.62e-03 | 14 | 127 | 2 | DOID:8725 (biomarker_via_orthology) | |
| Disease | Down syndrome (implicated_via_orthology) | 1.86e-03 | 15 | 127 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Endometrial Neoplasms | 2.02e-03 | 58 | 127 | 3 | C0014170 | |
| Disease | response to methotrexate | 2.12e-03 | 16 | 127 | 2 | GO_0031427 | |
| Disease | X-21441 measurement | 2.40e-03 | 17 | 127 | 2 | EFO_0800814 | |
| Disease | syndrome (implicated_via_orthology) | 2.69e-03 | 18 | 127 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | myocardial infarction (implicated_via_orthology) | 2.92e-03 | 66 | 127 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | Neoplastic Cell Transformation | 3.12e-03 | 139 | 127 | 4 | C0007621 | |
| Disease | Cardiomyopathies, Primary | 3.32e-03 | 69 | 127 | 3 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 3.32e-03 | 69 | 127 | 3 | C0036529 | |
| Disease | urinary microalbumin measurement | 3.32e-03 | 20 | 127 | 2 | EFO_0010967 | |
| Disease | Fetal Growth Retardation | 3.32e-03 | 20 | 127 | 2 | C0015934 | |
| Disease | end stage renal disease (implicated_via_orthology) | 3.32e-03 | 20 | 127 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | Sclerocystic Ovaries | 3.54e-03 | 144 | 127 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 3.54e-03 | 144 | 127 | 4 | C0032460 | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 3.66e-03 | 21 | 127 | 2 | DOID:11612 (biomarker_via_orthology) | |
| Disease | Endometrial Carcinoma | 3.74e-03 | 72 | 127 | 3 | C0476089 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KNSDFYMGAGGPLEH | 16 | Q15699 | |
| NDGHFMPVLGFGTYA | 11 | P17516 | |
| HGEMVSGFGPIYNYK | 246 | P04003 | |
| DYDSDKMFPALGFGA | 351 | Q96FN4 | |
| KVLPGGDTYMHEGFE | 111 | Q9H6X2 | |
| GFDHFYGMPFSLMGD | 166 | P51690 | |
| MKVYYDGTVEQHPFG | 131 | Q7Z4R8 | |
| NDGHFMPVLGFGTYA | 11 | P42330 | |
| IYFGMPGEISEHEGF | 296 | P51693 | |
| YFGPDNTGDIMTLKF | 201 | Q8IYT2 | |
| YDADKMFPAFGFGAQ | 336 | O75131 | |
| NLHGGELVVSYPFDM | 496 | Q96SM3 | |
| YPGEESDKHFMQNFA | 1026 | Q5JWR5 | |
| MEDGPVFYGFKNIFI | 1 | Q8WXH4 | |
| HFKMQIFGDRQPGYD | 71 | Q9HCK5 | |
| YAQGADSVEPMFKHL | 486 | Q9HCK5 | |
| GLEFYMGKFHKACFP | 241 | Q00975 | |
| YLNAGPMLFSGDKDH | 1411 | Q14004 | |
| TGLFTKPMHGYNFVV | 686 | Q8TE58 | |
| PFGENCFYKHMYPDG | 416 | Q13434 | |
| YGFCPHEALFTMGGN | 271 | P08253 | |
| ENFEDPMGTIDKFHY | 2081 | Q6ZS30 | |
| EHFLFMYKDPRTGGS | 481 | Q5U651 | |
| TYKAFLPAMIANDHG | 156 | Q8N3Y7 | |
| MQHFPGFAYINGEAS | 716 | Q33E94 | |
| PDTFSYGGHEDFSKM | 126 | Q8IXN7 | |
| LSFPYGHLSFGFMQD | 216 | P34810 | |
| PGGKHNMDFYVEALA | 241 | Q9UM07 | |
| YGAHKYQAEFPMSPV | 371 | P59901 | |
| PKVVYFGDSMHSDIF | 306 | Q5TFE4 | |
| MQAFHSPKALFPVGY | 4566 | Q8NEZ4 | |
| AGMAVYHGKLLDGFF | 1061 | P46934 | |
| HGPTFAKAAQDYCGM | 436 | Q9NQZ7 | |
| DYLAFHPFDTGMTLG | 921 | Q86UX2 | |
| EYEEHRGKGSFPAMI | 301 | Q86VF7 | |
| MKGGFTGGDEYQKHF | 1 | O95050 | |
| KVNIFDMAGHPFFYE | 66 | Q9NZQ0 | |
| VDGGLYEHKTFMYPV | 196 | P60608 | |
| PPKSGNYFASHFFMG | 26 | O60291 | |
| FGGMGEFPNALYTHC | 421 | Q5VW00 | |
| MDFRGLPGNYHKEEN | 76 | Q9UK85 | |
| GFQMHYEKTPFDQLA | 146 | Q9Y6B2 | |
| QHTNPGAFGKSDMYI | 211 | P53370 | |
| FPHYFGKEIIGGMLD | 841 | Q2TBE0 | |
| MKHEIGEFPVFFFGS | 911 | O96028 | |
| YKPEFASAMGINTAH | 481 | Q96LU7 | |
| GPFYFMAKEAGIENV | 1526 | Q92887 | |
| EEMEGYGPLKAHPFF | 301 | Q6A1A2 | |
| HFSSYSKDGIGVPFM | 226 | Q86V85 | |
| PALYQHIKTGFNMDD | 1281 | Q7Z3U7 | |
| FKDYIPQAFPGGHSM | 541 | P49916 | |
| QMPYGDVLIHAGDFT | 106 | O15442 | |
| VAGFLEGYLTAPHMN | 101 | Q6P4A8 | |
| SNGHIAYFPAMKAFV | 801 | Q9Y2A7 | |
| QFGGAVMYPSKETAH | 46 | O75306 | |
| FYFVMGGICDPGNSH | 476 | P78509 | |
| SIMEGHYYDPLQFQG | 541 | O15234 | |
| DPAVMGGFANYEKAF | 1531 | Q14185 | |
| DPAVMGGFSNYEKAF | 1556 | Q9H7D0 | |
| IYPFDGHNEGTLAMK | 546 | Q5T0N5 | |
| IGIPEFKYVANMHGD | 71 | P14384 | |
| IQDNAHMAEGTGFYP | 151 | Q9Y3I1 | |
| LGDMIFFHSYKNPGL | 241 | P49366 | |
| MDFRGNIFGSHYFDP | 96 | Q9GZV9 | |
| DYDSDKMFPAFGFGA | 351 | Q96A23 | |
| HASLGGFPVEKYMDV | 156 | P35453 | |
| PGEIQHFSKFYAGQM | 396 | Q9Y2G2 | |
| LDQFHDKTPYTIMFG | 176 | P27824 | |
| DDPAMFGAKGLSYDF | 441 | Q9NZK5 | |
| ADKERSGPYGFHEMQ | 981 | O75165 | |
| YALMPHKGSFQDAGV | 906 | Q9NTJ4 | |
| QMHLGGKQREYEFFG | 176 | Q8N6P7 | |
| MFNKNGDAPGRYDIF | 466 | Q14831 | |
| AHDGPVFAMYALDKG | 901 | Q6ZMW3 | |
| MFDPHHFLDEGGNFK | 406 | P11712 | |
| SGYAGFIMPIEVHFK | 76 | Q03111 | |
| LHRYDHGTFFPMGDE | 671 | Q9UBN7 | |
| LKFHIYNMGNPGFEE | 271 | P34947 | |
| YHMGQAGFPEARAVF | 276 | P43250 | |
| QDKPFAFFGHSMGSY | 91 | Q9NV23 | |
| MYIFKQPHFGGEVSP | 141 | Q5SRE7 | |
| QHYDSDKMFPALGFG | 371 | Q9HCH3 | |
| KMGAPEAGLAEYLFN | 121 | P0C7X4 | |
| TDSMEDFYPNKNHGP | 331 | Q5VUJ6 | |
| MFDFLHLTGGGYAKI | 191 | P68402 | |
| FGNRHDAVYGPADTM | 176 | Q9H944 | |
| FHYPFLGAMGDHSKK | 6 | Q96A47 | |
| PEAAAGVLEYAMKHF | 1426 | P42345 | |
| FYELGEPQAAMFKVG | 881 | Q99683 | |
| PVFNHTMVYDGFGPA | 471 | Q8IYJ3 | |
| MVFNGPFAHKEGPNY | 381 | Q13275 | |
| MIHGESGFFPINYVE | 326 | Q99963 | |
| PMINFDFHQFAKGGK | 331 | O15056 | |
| GSHVPLEQMSDFYGK | 191 | Q86UY8 | |
| LKMAGAFQFGHFVGP | 146 | Q7RTZ1 | |
| SMQPHGVFYEKDYEG | 481 | Q9BQS7 | |
| GDMYPETHLGRFFAF | 461 | Q8TDN2 | |
| RVENYDHKAMVPFGF | 216 | Q9P2F8 | |
| HFELMPGNSVYHFDK | 181 | Q8WTS6 | |
| LFKGHPDLIMGFNTF | 171 | Q96ST3 | |
| AFPSEHFGKLFGLVM | 416 | Q8NBI5 | |
| AGMPFLTGFYSKDHI | 381 | P03915 | |
| LVYGTMPFDGFDHKN | 246 | O60285 | |
| GEHVPRFFVMYADGS | 1636 | Q6Q759 | |
| NDGHFMPVLGFGTYA | 11 | Q04828 | |
| NDGHFMPVLGFGTYA | 11 | P52895 | |
| KTYMGLRNHFPGEAE | 276 | O75122 | |
| MTHFNKGPSYGLSAE | 1 | Q15417 | |
| YGMKPHDIFEANDLF | 96 | Q15417 | |
| NYEAMIDRAHGGPNF | 1816 | A5YKK6 | |
| EGQFKDNMFHGLGTY | 16 | Q502X0 | |
| YDPKHANVALFSDGM | 176 | Q9H3T3 | |
| CGKAFIYPTSFQGHM | 501 | Q3KP31 | |
| HFAKDCFMQPGGTKY | 141 | Q9NP64 | |
| KYETEFHPGTTSFGM | 61 | Q96QD8 | |
| RNPKGFGYVTFMHLE | 466 | Q9Y4K3 | |
| MGSLKYPDENGFDAF | 241 | O43847 | |
| NLKEHMPTFLFNGYE | 646 | O94885 | |
| ILPMFAKGASGDHVY | 141 | O95427 | |
| ELGTNYPKDMFDPHG | 176 | Q9UHR5 | |
| TMQDPFGEKRGHFDY | 296 | Q9H832 | |
| VGFSFAYMGKELPTN | 741 | Q8TE23 | |
| AEQYPKFESMGDHGY | 531 | Q5HYM0 | |
| YKPDGGCMHVAENFS | 246 | Q8N9V7 | |
| AYMVLFDFGNLQPGH | 176 | Q99536 | |
| SHDFKYGLMPGPSND | 656 | Q96DT7 | |
| AYLSMFGKEDHKPFG | 396 | Q5SRH9 | |
| GNTSPVTYNMFGHFK | 246 | Q7Z769 | |
| DGPGKYQLFAFISHM | 796 | P45974 | |
| DPHYVTFDGRHFGFM | 1161 | Q9Y493 | |
| LMFADGGTYLGHFEN | 31 | Q8NDC4 | |
| KDGMFHGEGTLYFPS | 36 | Q5VZ52 | |
| LQYGAEGGMLHTFFK | 216 | Q96M32 | |
| FSHNVGPGDKYTCMF | 51 | Q969H8 |